Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) Sees Significant Drop in Short Interest

Share on StockTwits

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) was the target of a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 17,100 shares, a drop of 54.6% from the August 30th total of 37,700 shares. Approximately 0.2% of the company’s shares are short sold. Based on an average trading volume of 41,700 shares, the short-interest ratio is currently 0.4 days.

Shares of NVIV traded up $0.02 during trading on Friday, reaching $0.50. 6,191 shares of the company traded hands, compared to its average volume of 15,944. Invivo Therapeutics has a twelve month low of $0.45 and a twelve month high of $2.75. The stock has a market cap of $4.56 million, a PE ratio of -0.22 and a beta of 1.54. The stock has a 50-day simple moving average of $0.57 and a 200-day simple moving average of $0.90. The company has a quick ratio of 5.72, a current ratio of 5.72 and a debt-to-equity ratio of 0.11.

Invivo Therapeutics (NASDAQ:NVIV) last announced its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.34) earnings per share for the quarter. On average, equities research analysts predict that Invivo Therapeutics will post -1.25 EPS for the current year.

About Invivo Therapeutics

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for implantation at the site of injury within a spinal cord.

Featured Story: Technical Analysis of Stocks, How Can It Help

Receive News & Ratings for Invivo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invivo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.